A 52-year-old man underwent partial splenic embolization (PSE) for hypersplenism. The intrasplenic artery targeted for the embolization was large, and the distance between its trifurcated branches was short; therefore, Guglielmi detachable coils (GDC) 360°Complex Shape were used, as well as conventional metal coils, to prevent coil migration. GDC are equipped with a shape-memory function and are more physically stable than conventional metallic coils because they form three-dimensional loops. In this case, an ideal extent of the splenic infarction was successfully achieved using a small number of coils. This is the first report of the use of GDC in PSE for hypersplenism.
Introduction
A 52-year-old man, who had a low platelet count due to hypersplenism accompanying splenomegaly with hepatitis C cirrhosis, underwent partial splenic embolization (PSE). PSE is typically performed by inserting metallic coils into the splenic artery. However, in the present case, the patient's intrasplenic arteries targeted for the embolization were too large, and the distance between its trifurcated branches was short, thus, there was a risk that the implanted coils would migrate instead of dwelling at the optimal sites, leading to an inappropriate splenic infarction. Therefore, we attempted to use the highly stable Guglielmi detachable coils (GDC) 360°Complex Shape , Stryker Neurovascular, Fremont, USA in addition to conventional metal coils. GDC are equipped with a shape-memory function and are more physically stable than conventional metallic coils because they are able to form three-dimensional loops (Fig. 1 ). Since 2008, GDC have been indicated for use in abdominal and peripheral blood vessels, in addition to their conventional use in craniocervical blood vessels. As a result, GDC are highly stable and allow the operator to conduct embolization of the splenic tissue in an accurate and reliable manner. The use of GDC in abdominal procedures has previously been reported in the treatment of aneurysms and vascular malformations; however, to the best of our knowledge, this is the first report of the successful use of GDC in PSE.
Case Report
A 52-year-old man with a low platelet count was diagnosed with hypersplenism accompanying splenomegaly with hepatitis C cirrhosis and treatment with PSE was recommended.
The patient received a blood transfusion at the age of 14 years after being injured in a traffic accident. At the age of 45 years, a local doctor suspected liver cirrhosis (LC), however, the patient did not undergo a regular medical examination at the hospital. He had a 32-year history of alcohol consumption (600 mL per day of beer). Upon admission to our hospital, his Child-Pugh score was nine points and was classified as grade B. His platelet count was 3.3×10 4 g/dL. The level of hepatitis C viral RNA (HCV-RNA) was 5.1 log IU/mL (via the TaqMan method), and the HCV genotype was type 2a (Table 1) . Contrast-enhanced computed tomography showed atrophy of the liver in addition to splenomegaly and collateral circulation, findings that were Figure 1 . The platinum coil is connected to a stainless steel guide wire and can be detached from the latter by turning on electricity. Therefore, it can be inserted and pulled out freely until it is detached. After the coil has been delivered into the blood vessel in a 360 degree complex shape, the electricity is turned on. As a result, the shape-memory function is activated, and the coil takes on a shape that allows it to fit inside the blood vessel. Later, effective thrombosis can be achieved by adding a small coil inside. compatible with LC. Additionally, slight ascites was found. Therefore, branched-chain amino acids (BCAA), diuretics, and ursodeoxycholic acid were administrated by the referring physicians and this treatment was continued after the patient was transferred to our hospital. After this admission, the patient was diagnosed with esophageal varices (EV), classified as Form3Red Color sign1 (F3RC1) by esophagogastroduodenoscopy, thus endoscopic variceal ligation (EVL) was performed. After a month, PSE with six coils, two of which were GDC, was performed ( Fig. 2 ) and an infarction rate of approximately 85% was obtained (Fig. 3) . Because the middle branch of the splenic artery targeted for the embolization exceeded 10 mm, the procedure was predicted to require the use of a considerable number of Figure 2 . The image is a contrast-enhanced image taken from the splenic artery trunk. The distance from the splenic artery to its trifurcation into the superior, middle and inferior branches was short; the middle branch that was targeted for embolization was as large as 11 mm in diameter. PSE was performed using a total of six coils, including two GDC (arrow). metal coils. Furthermore, the intrasplenic trifurcations of the artery into the superior, middle and inferior branches were close to each other; thus, the in-dwelling metal coil would potentially be unstable and the resulting splenic infarction would likely extend to a broader area than anticipated. Therefore, we used the highly stable GDC in addition to the conventional metal coils in the present case. As a result, an ideal extent of the infarction was achieved, and the total number of coils utilized was successfully reduced to 6. After PSE, the patient had a fever higher than 37 from the third hospital day to the 11th hospital day, with a maximum temperature of 38.3 ; additionally, the maximum C-reactive protein (CRP) concentration was 4.8 mg/dL, however, it improved following antimicrobial administration. After the PSE procedure, there was no complication of portal vein thrombosis, splenic abscess, hepatic infarction or multiple organ failure. Ascites increased slightly but was later reduced by continuous BCAA administration and an increased administration of diuretics, and the patient was discharged on the 16th hospital day. However, two months after PSE, the patient's condition was complicated by bacterial peritonitis, and consequently, he was rehospitalized. Upon administration of the antibacterial agents, his condition improved and was not complicated with sepsis. Four weeks later, he was discharged from the hospital. The patient's platelet count gradually improved, and one year after PSE, his count was 15×10 4 g/dL. The Child-Pugh score decreased to 5 points, which indicated that his condition had improved to grade A. In addition, a considerable improvement of the EV was found, and no hepatocellular carcinoma (HCC) was detected. In our experience with the present case, thrombocytopenia improved, and treatment with pegylated interferon (Peg-IFN) α2a and ribavirin (RBV) could be administered. Currently, the patient remains negative for HCV-RNA, his recent platelet count was 13×10 4 g/dL, and his condition is still grade A according to the Child-Pugh score.
Discussion
LC causes portal hypertension leading to various extrahepatic complications. Hypersplenism is one such complication and leads to pancytopenia, worsening of collateral circulation, and a worsened prognosis of LC (1, 2). Thrombocytosis can certainly be achieved through splenectomy. However, complications such as post-operative portal vein thrombosis and decreased immunocompetence due to overwhelming infection following splenectomy have been viewed as problematic issues. In 1979, Spigos et al. developed PSE, a treatment in which the splenic artery (not its trunk) is partially embolized while a part of the spleen is preserved (3). Due to the immunological role of the spleen, preservation of 30% or more of the healthy spleen is important when performing PSE (4). As such, PSE is currently being reconsidered as an alternative treatment for hypersplenism (5) .
A recent study has suggested that PSE has improved outcomes with respect to thrombocytopenia and portal hypertension (1). PSE has been established as a minimally invasive procedure due to the improvements in the technical aspects and embolic materials. In addition, the rate of increase in the platelet counts and the splenic infarction rate have We reviewed recent reports and found that PSE and bacterial peritonitis may be associated, to some extent, with the development of splenic abscesses following PSE. The ratio of the incidence of splenic abscess to bacterial peritonitis was 4.3%:4.3% according to Elmonem et al. (7) and 1.6%: 1.6% according to Zhu et al. (8) ; it occurred within one month after PSE in all the cases. Conversely, as shown in the ratio (5%:0%) reported by Amin et al. (9) and that (6.3%:0%) reported by N'Kontchou et al. (10) , several studies have demonstrated that splenic abscess was not complicated by bacterial peritonitis even in the patients who developed splenic abscesses. On the contrary, there were no reports of bacterial peritonitis occurring after PSE. In the present case, the patient did not have complications of a splenic abscess, and bacterial peritonitis occurred two months after PSE. Therefore, we believe that there is no definite causal relationship between bacterial peritonitis and PSE. Because patients with LC are immunologically susceptible to infection, such as bacteremia, an infection unrelated to PSE may have occurred in the present case.
Metallic coils for use in the abdominal area have long consisted of mechanical detachable coils forming twodimensional loops inside the blood vessels. The occurrence of unexpected infarction due to the movement of the coils is common, and because the infarction range covers a large area of the spleen, multiple metallic coils are needed. In Japan, GDC were approved for use in the craniocervical blood vessels in 1997, and since 2008, their indications have also been expanded to the abdominal and peripheral blood vessels. GDC were indicated for the following cases: "it can be used for embolization for vascular lesions such as aneurysms, arteriovenous malformation and arteriovenous fistula in the brain and embolization for vascular lesions, such as cervical aneurysms, cervical vascular malformation, pulmonary vascular malformation, renovascular malformation, renal aneurysm, and abdominal aneurysm" in the attached document. The reports on the use of GDC in the abdominal area have mainly comprised the device being used for the treatment of abdominal artery aneurysms. The reports pertaining to the spleen accounted for only two research studies, both of which were related to splenic aneurysms and not PSE (11, 12) . The uniqueness of GDC is due to their increased stability, as compared to conventional metallic coils, because they have a shape-memory function and can form three-dimensional loops. GDC are not designed to achieve full embolization, but rather to allow for an effective thrombus formation through the appropriate placement of indwelling conventional coils after the insertion of the device as an anchor. Therefore, sufficient embolization can be achieved using a smaller total number of coils, and the migration of the in-dwelling coils can be prevented (13, 14) . In addition, since large-sized variants of the device are also available, relatively large arteries can easily be embolized. These features of GDC render them attractive for use in PSE. Table 2 shows a comparison of a frequently used conventional coil and a GDC.
There are some side reactions and disadvantages that are anticipated when a GDC is used. GDC are recoverable and therefore, unlike with conventional coils, they will not end up departing from the expected embolic area and causing a side reaction, nor will they appear on magnetic resonance imaging (MRI) because they are composed of platinum. However, GDC have a disadvantage in that they cannot be formed to the ideal memory shape type unless the expected embolic artery diameter has been accurately measured to select an optimally sized GDC. Ordinarily, one guideline is that selecting a GDC of 1.5 times the length of the expected embolic artery diameter makes a favorable fit possible. Though a memory shape may be formed successfully using a long GDC, it will later be necessary to add a small coil to fill in the gap. Another disadvantage is that cost-benefit problems arise if many GDC are used because they are more expensive than conventional coils. We used GDC for the embolization of thick splenic arteries like that found in the case described in this study. As a result, reliable and safe coiling was achieved with a small number of coils and without migration of the in-dwelling coils as described in the present case. According to the findings from studies that we have conducted since 2012 to the present, an average of 14 conventional metal coils is needed in order to ensure an ideal extent of the splenic infarction in PSE for the treatment of hypersplenism. Table 3 shows the PSE results of interlock detachable coil (IDC) in our facility. Compared with the conventional method, the use of GDC allows for the reduction of the total number of coils needed and increases the safety of the procedure. This study is the first report of the use of GDC for PSE; we herein demonstrated the safe and efficient use of GDC in PSE, and this method has great potential for future clinical management of hypersplenism.
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